News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,941 Results
Type
Article (6389)
Company Profile (48)
Press Release (217504)
Section
Business (63860)
Career Advice (340)
Deals (12711)
Drug Delivery (25)
Drug Development (18589)
Employer Resources (28)
FDA (6461)
Job Trends (5184)
News (103992)
Policy (8635)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
Academia (672)
Accelerated approval (1)
Adcomms (1)
Allergies (31)
Alliances (21511)
ALS (23)
Alzheimer's disease (385)
Antibody-drug conjugate (ADC) (14)
Approvals (6471)
Artificial intelligence (133)
Autoimmune disease (3)
Automation (14)
Bankruptcy (81)
Best Places to Work (4730)
BIOSECURE Act (3)
Biosimilars (33)
Biotechnology (36)
Bladder cancer (19)
Brain cancer (8)
Breast cancer (65)
Cancer (447)
Cardiovascular disease (32)
Career advice (294)
Career pathing (8)
CAR-T (18)
Cell therapy (82)
Cervical cancer (4)
Clinical research (15393)
Collaboration (367)
Compensation (60)
Complete response letters (8)
COVID-19 (825)
CRISPR (10)
C-suite (58)
Cystic fibrosis (22)
Data (508)
Decentralized trials (2)
Denatured (2)
Depression (12)
Diabetes (70)
Diagnostics (3128)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (40)
Drug pricing (22)
Drug shortages (7)
Duchenne muscular dystrophy (5)
Earnings (21994)
Editorial (5)
Employer resources (26)
Events (28515)
Executive appointments (236)
FDA (6874)
Featured Employer (12)
Frontotemporal dementia (1)
Funding (265)
Gene editing (21)
Generative AI (12)
Gene therapy (60)
GLP-1 (205)
Government (946)
Grass and pollen (2)
Guidances (15)
Healthcare (6795)
Huntington's disease (4)
IgA nephropathy (2)
Immunology and inflammation (11)
Indications (9)
Infectious disease (870)
Inflammatory bowel disease (41)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (37)
Interviews (56)
IPO (5340)
IRA (5)
Job creations (652)
Job search strategy (236)
Kidney cancer (2)
Labor market (2)
Layoffs (64)
Leadership (4)
Legal (1412)
Liver cancer (11)
Lung cancer (72)
Lymphoma (27)
Machine learning (1)
Management (13)
Manufacturing (135)
MASH (10)
Medical device (7102)
Medtech (7105)
Mergers & acquisitions (7615)
Metabolic disorders (160)
Multiple sclerosis (15)
NASH (2)
Neurodegenerative disease (20)
Neuropsychiatric disorders (3)
Neuroscience (511)
NextGen: Class of 2025 (2606)
Non-profit (1100)
Northern California (613)
Now hiring (6)
Obesity (89)
Opinion (50)
Ovarian cancer (10)
Pain (38)
Pancreatic cancer (15)
Parkinson's disease (36)
Partnered (9)
Patents (82)
Patient recruitment (27)
Peanut (17)
People (16453)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase I (4112)
Phase II (6442)
Phase III (5970)
Pipeline (252)
Podcasts (2)
Policy (11)
Postmarket research (621)
Preclinical (1572)
Press Release (22)
Prostate cancer (19)
Psychedelics (9)
Radiopharmaceuticals (73)
Rare diseases (94)
Real estate (1972)
Recruiting (6)
Regulatory (6827)
Reports (14)
Research institute (684)
Resumes & cover letters (51)
Rett syndrome (1)
RSV (6)
Schizophrenia (18)
Series A (44)
Series B (29)
Service/supplier (7)
Sickle cell disease (14)
Southern California (577)
Special edition (2)
Sponsored (17)
Startups (970)
State (2)
Stomach cancer (1)
Supply chain (29)
United States (6834)
Vaccines (181)
Venture capitalists (2)
Webinars (4)
Weight loss (59)
Women's health (15)
Worklife (3)
Date
Today (52)
Last 7 days (248)
Last 30 days (1083)
Last 365 days (12420)
2025 (2208)
2024 (12683)
2023 (14292)
2022 (20541)
2021 (22294)
2020 (21939)
2019 (18878)
2018 (13797)
2017 (11657)
2016 (10740)
2015 (12225)
2014 (8728)
2013 (7205)
2012 (7712)
2011 (7533)
2010 (6393)
Location
Africa (170)
Alabama (23)
Alaska (2)
Arizona (58)
Arkansas (4)
Asia (12223)
Australia (1664)
California (1520)
Canada (743)
China (123)
Colorado (116)
Connecticut (97)
Delaware (51)
Europe (30688)
Florida (283)
Georgia (108)
Idaho (42)
Illinois (217)
India (11)
Indiana (177)
Iowa (4)
Japan (51)
Kansas (49)
Kentucky (6)
Louisiana (3)
Maine (26)
Maryland (268)
Massachusetts (1036)
Michigan (113)
Minnesota (212)
Mississippi (2)
Missouri (44)
Montana (20)
Nebraska (12)
Nevada (19)
New Hampshire (38)
New Jersey (577)
New Mexico (16)
New York (414)
North Carolina (427)
North Dakota (6)
Northern California (613)
Ohio (80)
Oklahoma (6)
Oregon (14)
Pennsylvania (371)
Puerto Rico (3)
Rhode Island (11)
South America (323)
South Carolina (10)
South Dakota (1)
Southern California (577)
Tennessee (36)
Texas (247)
Utah (51)
Virginia (52)
Washington D.C. (14)
Washington State (112)
West Virginia (2)
Wisconsin (39)
223,941 Results for "formulated solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Could New Leqembi Formulations Boost Lagging Sales in Alzheimer’s?
The FDA accepted Biogen and Eisai’s BLA for a subcutaneous administration of the anti-amyloid antibody Monday as the partners await the regulator’s decision on a new intravenous regimen following an underwhelming launch riddled with coverage and accessibility barriers.
January 14, 2025
·
1 min read
·
Kate Goodwin
Business
Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine
Revive Therapeutics Ltd. is pleased to announce that it has signed a collaboration agreement with Attwill Medical Solutions LP (“AMS”) for the clinical and commercial development of the Company’s next-generation lyophilized formulation of Bucillamine.
December 18, 2023
·
4 min read
Press Releases
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
February 3, 2025
·
5 min read
Press Releases
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 18, 2024
·
3 min read
Press Releases
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
March 4, 2025
·
8 min read
Press Releases
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
January 22, 2025
·
4 min read
Press Releases
Onco-Innovations’ Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
February 17, 2025
·
9 min read
Press Releases
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
January 14, 2025
·
4 min read
Press Releases
New Alliance for the Development of a Sublingual Oxytocin Formulation to Prevent Postpartum Hemorrhage
November 21, 2024
·
6 min read
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
Spektar Therapeutics FZCO and Altus Formulation Inc. announced the launch of Spektus Pharma Inc. a new Canadian specialty pharma company developing patent-protected value-added medicines for the growing CNS segment.
June 18, 2024
·
2 min read
1 of 22,395
Next
